Drugs / PM1015
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05950815 | May 2022 → Sep 2023 | — | BioNTech SE | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PM1015 | “PM1015 is a specific antibody targeting CD73.” NCT05950815 ↗ |
| Modality | Protein / enzyme biologic | “PM1015 is a specific antibody targeting CD73.” NCT05950815 ↗ |